A follow up phase 2 study of the topical formulation of FOL-005 for the treatment of hair loss
Phase of Trial: Phase II
Latest Information Update: 12 Nov 2019
Price : $35 *
At a glance
- Drugs FOL 005 (Primary)
- Indications Alopecia
- Focus Proof of concept; Therapeutic Use
- Sponsors Follicum AB
- 12 Nov 2019 According to an Follicum AB media release, the company intends to submit the application for starting the phase IIa study with the new formulation to the German Federal Institute for Drugs and Medical Devices (BfArM) in November.
- 12 Nov 2019 According to an Follicum AB media release, the company has signed a collaboration agreement with proDERM for conducting this new clinical trial with a cream-like formulation of FOL-005. This study will be carried out at two clinics in part at Charite University Hospital and at proDERM.
- 22 Oct 2019 According to a Follicum AB media release, the company announced that if this study continues in accordance with the communicated time plan they expect the top-line data during autumn 2020.